vs
Side-by-side financial comparison of PEGASYSTEMS INC (PEGA) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($783.7M vs $430.0M, roughly 1.8× PEGASYSTEMS INC). Insulet Corporation runs the higher net margin — 13.0% vs 7.6%, a 5.3% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs -9.6%). PEGASYSTEMS INC produced more free cash flow last quarter ($206.5M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 10.7%).
Pegasystems Inc. (Pega) is a global software company based in Waltham, Massachusetts, in the United States, and founded in 1983. The company has been publicly traded since 1996 as PEGA (NASDAQ). Pega is a low-code platform for workflow automation and generative AI-powered decision-making for businesses.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
PEGA vs PODD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $430.0M | $783.7M |
| Net Profit | $32.8M | $101.6M |
| Gross Margin | 75.2% | 72.6% |
| Operating Margin | 8.6% | 18.7% |
| Net Margin | 7.6% | 13.0% |
| Revenue YoY | -9.6% | 31.2% |
| Net Profit YoY | — | 0.9% |
| EPS (diluted) | $0.18 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $430.0M | — | ||
| Q4 25 | $504.3M | $783.7M | ||
| Q3 25 | $381.4M | $706.3M | ||
| Q2 25 | $384.5M | $649.1M | ||
| Q1 25 | $475.6M | $569.0M | ||
| Q4 24 | $490.8M | $597.5M | ||
| Q3 24 | $325.1M | $543.9M | ||
| Q2 24 | $351.2M | $488.5M |
| Q1 26 | $32.8M | — | ||
| Q4 25 | $234.6M | $101.6M | ||
| Q3 25 | $43.4M | $87.6M | ||
| Q2 25 | $30.1M | $22.5M | ||
| Q1 25 | $85.4M | $35.4M | ||
| Q4 24 | $119.1M | $100.7M | ||
| Q3 24 | $-14.4M | $77.5M | ||
| Q2 24 | $6.6M | $188.6M |
| Q1 26 | 75.2% | — | ||
| Q4 25 | 79.5% | 72.6% | ||
| Q3 25 | 72.2% | 72.2% | ||
| Q2 25 | 71.5% | 69.7% | ||
| Q1 25 | 78.5% | 71.9% | ||
| Q4 24 | 79.1% | 72.1% | ||
| Q3 24 | 70.2% | 69.3% | ||
| Q2 24 | 72.4% | 67.7% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 20.7% | 18.7% | ||
| Q3 25 | 3.8% | 16.7% | ||
| Q2 25 | 4.5% | 18.7% | ||
| Q1 25 | 26.7% | 15.6% | ||
| Q4 24 | 29.1% | 18.3% | ||
| Q3 24 | -3.6% | 16.2% | ||
| Q2 24 | 3.7% | 11.2% |
| Q1 26 | 7.6% | — | ||
| Q4 25 | 46.5% | 13.0% | ||
| Q3 25 | 11.4% | 12.4% | ||
| Q2 25 | 7.8% | 3.5% | ||
| Q1 25 | 18.0% | 6.2% | ||
| Q4 24 | 24.3% | 16.9% | ||
| Q3 24 | -4.4% | 14.2% | ||
| Q2 24 | 1.9% | 38.6% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $0.81 | $1.42 | ||
| Q3 25 | $0.24 | $1.24 | ||
| Q2 25 | $0.17 | $0.32 | ||
| Q1 25 | $0.91 | $0.50 | ||
| Q4 24 | $1.35 | $1.38 | ||
| Q3 24 | $-0.17 | $1.08 | ||
| Q2 24 | $0.07 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $270.0M | — |
| Total DebtLower is stronger | — | $930.8M |
| Stockholders' EquityBook value | $705.9M | $1.5B |
| Total Assets | $1.6B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $270.0M | — | ||
| Q4 25 | $425.8M | — | ||
| Q3 25 | $351.4M | — | ||
| Q2 25 | $411.6M | — | ||
| Q1 25 | $371.7M | — | ||
| Q4 24 | $740.0M | — | ||
| Q3 24 | $703.0M | — | ||
| Q2 24 | $665.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | $705.9M | — | ||
| Q4 25 | $787.4M | $1.5B | ||
| Q3 25 | $596.8M | $1.4B | ||
| Q2 25 | $624.5M | $1.5B | ||
| Q1 25 | $611.3M | $1.3B | ||
| Q4 24 | $585.5M | $1.2B | ||
| Q3 24 | $473.0M | $1.1B | ||
| Q2 24 | $435.4M | $998.4M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $3.2B | ||
| Q3 25 | $1.3B | $3.0B | ||
| Q2 25 | $1.3B | $3.5B | ||
| Q1 25 | $1.3B | $3.5B | ||
| Q4 24 | $1.8B | $3.1B | ||
| Q3 24 | $1.6B | $3.0B | ||
| Q2 24 | $1.5B | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $183.3M |
| Free Cash FlowOCF − Capex | $206.5M | $48.2M |
| FCF MarginFCF / Revenue | 48.0% | 6.2% |
| Capex IntensityCapex / Revenue | — | 17.2% |
| Cash ConversionOCF / Net Profit | — | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $494.9M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.4M | $183.3M | ||
| Q3 25 | $56.3M | $125.7M | ||
| Q2 25 | $86.3M | $196.5M | ||
| Q1 25 | $204.2M | $63.8M | ||
| Q4 24 | $95.2M | $147.7M | ||
| Q3 24 | $30.5M | $98.5M | ||
| Q2 24 | $40.1M | $96.5M |
| Q1 26 | $206.5M | — | ||
| Q4 25 | $152.4M | $48.2M | ||
| Q3 25 | $51.8M | $100.1M | ||
| Q2 25 | $84.1M | $177.9M | ||
| Q1 25 | $202.3M | $51.5M | ||
| Q4 24 | $92.4M | $94.1M | ||
| Q3 24 | $27.4M | $71.8M | ||
| Q2 24 | $38.8M | $74.0M |
| Q1 26 | 48.0% | — | ||
| Q4 25 | 30.2% | 6.2% | ||
| Q3 25 | 13.6% | 14.2% | ||
| Q2 25 | 21.9% | 27.4% | ||
| Q1 25 | 42.5% | 9.1% | ||
| Q4 24 | 18.8% | 15.7% | ||
| Q3 24 | 8.4% | 13.2% | ||
| Q2 24 | 11.1% | 15.1% |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 17.2% | ||
| Q3 25 | 1.2% | 3.6% | ||
| Q2 25 | 0.6% | 2.9% | ||
| Q1 25 | 0.4% | 2.2% | ||
| Q4 24 | 0.6% | 9.0% | ||
| Q3 24 | 0.9% | 4.9% | ||
| Q2 24 | 0.4% | 4.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.68× | 1.80× | ||
| Q3 25 | 1.30× | 1.43× | ||
| Q2 25 | 2.87× | 8.73× | ||
| Q1 25 | 2.39× | 1.80× | ||
| Q4 24 | 0.80× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | 6.06× | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PEGA
| Pega Cloud | $205.0M | 48% |
| Subscription license | $94.9M | 22% |
| Maintenance | $75.3M | 18% |
| Consulting | $54.8M | 13% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
